Cargando…

Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study

INTRODUCTION: Data on burden of pulmonary arterial hypertension (PAH) are mostly limited to physical and clinical endpoints as well as quality of life. Research on employment, work productivity, and educational background is scarce. The aim of this study was to assess the impact of PAH on employment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuge, Jan, Park, Da-Hee, von Lengerke, Thomas, Richter, Manuel J., Gall, Henning, Ghofrani, Hossein A., Kamp, Jan C., Hoeper, Marius M., Olsson, Karen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861193/ https://www.ncbi.nlm.nih.gov/pubmed/35211036 http://dx.doi.org/10.3389/fpsyt.2021.781532

Ejemplares similares

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Park, Da Hee, et al.
Publicado: (2021)

Childhood Trauma in Patients With PAH—Prevalence, Impact on QoL, and Mental Health—A Preliminary Report
por: Park, Da-Hee, et al.
Publicado: (2022)

Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
por: Caldarone, Flora, et al.
Publicado: (2022)

Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Dering, Madelaine-Rachel, et al.
Publicado: (2022)

Childhood Maltreatment, Mental Well-Being, and Healthy Lifestyle in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Lepsy, Nicole, et al.
Publicado: (2022)

Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Olsson, Karen M., et al.
Publicado: (2021)

Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial Hypertension
por: Park, Da-Hee, et al.
Publicado: (2022)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2020)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
por: Kamp, Jan C., et al.
Publicado: (2021)

Capillary pCO(2) helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction
por: Olsson, Karen M, et al.
Publicado: (2015)

Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2015)

Metacognitive Therapy for Adjustment Disorder in a Patient With Newly Diagnosed Pulmonary Arterial Hypertension: A Case Report
por: Winter, Lotta, et al.
Publicado: (2020)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
por: Grimminger, Jan, et al.
Publicado: (2017)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
por: Marra, Alberto M., et al.
Publicado: (2018)

An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan
por: Gall, Henning, et al.
Publicado: (2017)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Metacognitive Short-Term Intervention in Patients With Mental Disorders Following Cardiovascular Events
por: Gebhardt, Philippa, et al.
Publicado: (2022)

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
por: Kramm, Thorsten, et al.
Publicado: (2018)

Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Supported Employment, Participation at Work, and Peer Support: A Qualitative, Participatory Case Study Report of the Geesthacht Model
por: von Peter, Sebastian, et al.
Publicado: (2021)

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease
por: Wiedenroth, Christoph B., et al.
Publicado: (2017)

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
por: Knudsen, Lars, et al.
Publicado: (2011)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

Employers With Metabolic Syndrome and Increased Depression/Anxiety Severity Profit Most From Structured Exercise Intervention for Work Ability and Quality of Life.
por: Haufe, Sven, et al.
Publicado: (2020)

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
por: Eichstaedt, Christina A., et al.
Publicado: (2022)

Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension
por: Bandorski, Dirk, et al.
Publicado: (2023)

C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
por: Pink, Isabell, et al.
Publicado: (2021)

Predictors of Employment for People With Mental Illness: Results of a Multicenter Randomized Trial on the Effectiveness of Placement Budgets for Supported Employment
por: Rössler, Wulf, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a9618lnua3jmmct3lp178dq1um